Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.

about

Functional Impairment and Painful Physical Symptoms in Patients with Major Depressive Disorder Treated with Antidepressants: Real-World Evidence from the Middle East.

Item

http://www.wikidata.org/entity/Q47112259

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Functional Impairment and Pain ...... Evidence from the Middle East.

@en

Functional Impairment and Pain ...... Evidence from the Middle East.

@nl

type

Item

label

Functional Impairment and Pain ...... Evidence from the Middle East.

@en

Functional Impairment and Pain ...... Evidence from the Middle East.

@nl

prefLabel

Functional Impairment and Pain ...... Evidence from the Middle East.

@en

Functional Impairment and Pain ...... Evidence from the Middle East.

@nl

P1476

Functional Impairment and Pain ...... Evidence from the Middle East.

@en

P2093

Ahmed El-Shafei

http://www.w3.org/2001/XMLSchema#string

Héctor Dueñas

http://www.w3.org/2001/XMLSchema#string

Jihyung Hong

http://www.w3.org/2001/XMLSchema#string

Maria Victoria Moneta

http://www.w3.org/2001/XMLSchema#string

P2860

Duloxetine versus other anti-depressive agents for depression

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Depression and pain comorbidity: a literature review.

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

P304

145-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1745017901713010145

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Josep Maria Haro

Diego Novick

P577

2017-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29238391

http://www.w3.org/2001/XMLSchema#string

P921

Middle East

P932

5712648

http://www.w3.org/2001/XMLSchema#string